MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY for MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Amendment | Apr 30, 2013 | $450,000 | Replaced |
| 1st Quarter - Amendment (this page) | Apr 30, 2013 | $450,000 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
FDA related matters including issues related to "biosimilar products", prescription drug "track and trace" and orphan drug products
| Lobbyist | Covered position, as disclosed |
|---|---|
| AARTI SHAH | — |
Medicare/Medicaid MMM
S. Con. Res 8 -- Concurrent Resolution on the Budget for Fiscal Year 2014 H Con Res 25 -- Establishing the budget for the US Government for FY 2014 and setting forth appropriate budgetary levels for FY 15 through 2033 HR 933 -- Consolidated and Further Continuing Appropriations Act, 2013In all of the above specific issues included potential Medicare offsets that might be applied to prescription drugs, especially changes to ASP, physician payment and oncology matters
| Lobbyist | Covered position, as disclosed |
|---|---|
| AARTI SHAH | — |
Budget/Appropriations BUD
S. Con. Res 8 -- Concurrent Resolution on the Budget for Fiscal Year 2014 H Con Res 25 -- Establishing the budget for the US Government for FY 2014 and setting forth appropriate budgetary levels for FY 15 through 2033 HR 933 -- Consolidated and Further Continuing Appropriations Act, 2013In all of the above specific issues included potential Medicare offsets that might be applied to prescription drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| AARTI SHAH | — |
Health Issues HCR
Implementation of the new health care reform law - PL 111-148, specifically with regard to those provisions impacting Medicare/Medicaid prescription drug coverage in the essential benefit package, and other matters.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AARTI SHAH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.